SCM
RMD icon

Suvretta Capital Management’s ResMed RMD Stock Holding History

Suvretta Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Hold
2,390
– – 0.01% 91
2026
Q1 		$537K Hold
2,390
– – 0.01% 82
2025
Q4 		$576K Hold
2,390
– – 0.01% 86
2025
Q3 		$654K Hold
2,390
– – 0.02% 87
2025
Q2 		$617K Hold
2,390
– – 0.02% 87
2025
Q1 		$535K Hold
2,390
– – 0.02% 94
2024
Q4 		$547K Hold
2,390
– – 0.02% 90
2024
Q3 		$583K Hold
2,390
– – 0.02% 92
2024
Q2 		$457K Hold
2,390
– – 0.02% 90
2024
Q1 		$473K Buy
+2,390
New +$438K 0.02% 95

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Suvretta Capital Management's RMD Position: Q2 2026 in Review

Suvretta Capital Management held its ResMed (RMD) position steady in Q2 2026 at 2,390 shares worth $466K. The position accounts for 0.01% of the portfolio, ranked #91.

Suvretta Capital Management first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $654K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Suvretta Capital Management held 2,390 shares of ResMed worth $466K as of Q2 2026.
  • Suvretta Capital Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.01% of Suvretta Capital Management's portfolio in Q2 2026, its #91 holding.
  • Suvretta Capital Management first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Suvretta Capital Management's ResMed position peaked at $654K in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.